Envoy Medical (COCH) Gains from Investment Securities (2021 - 2026)
Envoy Medical (COCH) reported Gains from Investment Securities of $13000.0 for Q1 2026, up 103.09% on a YoY basis from $6401.2 in Q1 2025, and up 208.33% sequentially from -$12000.0 in Q4 2025.
Envoy Medical (COCH) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Envoy Medical (COCH) has 6 years of Gains from Investment Securities data on file, last reported at $13000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 103.09% year-over-year to $13000.0; the trailing twelve-month figure through Mar 2026 stood at -$457000.0 (up 58.23% YoY), and the FY2025 full-year result was -$534000.0, down 29.93% from the prior year.
- Gains from Investment Securities advanced to $13000.0 in Q1 2026, from -$12000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $693000.0 in Q3 2025 to a low of -$20.0 million in Q4 2022.
- A 5-year average of -$2.5 million and a median of -$203333.5 in 2023 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities sank 2911.97% in 2022 and jumped 291.19% in 2024, its largest moves.
- Tracing COCH's Gains from Investment Securities over 5 years: stood at -$20.0 million in 2022, then soared by 94.78% to -$1.0 million in 2023, then increased by 29.25% to -$740000.0 in 2024, then surged by 98.38% to -$12000.0 in 2025, then surged by 208.33% to $13000.0 in 2026.
- Business Quant data shows COCH's Gains from Investment Securities at $13000.0 in Q1 2026, -$12000.0 in Q4 2025, and $693000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn |
| 10 | Envoy Medical | 47.30 Mn | 22.05 Mn | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Sep 30, 2025 | 693,000.00 |
| Sep 30, 2025 | 693,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Mar 31, 2025 | -421,000.00 |
| Mar 31, 2025 | -421,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | -244,000.00 |
| Jun 30, 2024 | -244,000.00 |
| Mar 31, 2024 | 262,000.00 |
| Mar 31, 2024 | 262,000.00 |
| Dec 31, 2023 | -1.05 Mn |
| Dec 31, 2023 | -1.05 Mn |